ContraFect Chairman Steven C. Gilman Returns from Temporary Medical Leave YONKERS, NY--(Marketwired - May 30, 2017) - ContraFect Corporation (NASDAQ: CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics...

ContraFect Announces Second Quarter 2016 Results YONKERS, NY --(Marketwired - August 09, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...

ContraFect to Present at Jefferies 2016 Healthcare Conference YONKERS, NY--(Marketwired - June 01, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of...

Provista Diagnostics Announces Reelection of the Company's Board of Directors NEW YORK, NY, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a privately-held molecular diagnostics company developing and commercializing a new generation of proprietary blood-based...